ABT

Abbott Laboratories

92.71

Jun 29 • 04:00PM ET -1.41 (-1.50%)

Healthcare Medical Devices USA Large NYSE

Jun 25, 11:03 AMALZpath licensing deal for Alzheimer's blood test lifts Abbott 4.4%

Peers: MDT SYK BSX EW BDX ISRG BAX DHR ZBH TFX

| Held by: VTI SCHD VOO IVV SPY VTV XLV VIG VYM IHI

Scroll to Statements

Index	S&P 500
Market Cap	161.48B
Enterprise Value	188.88B
Income	6.28B
Sales	45.13B
Book/sh	29.89
Cash/sh	4.19
Dividend Est.	2.47 (2.67%)
Dividend TTM	2.44 (2.63%)
Dividend Ex-Date	Jul 15, 2026
Dividend Gr. 3/5Y	7.72% 9.42%
Payout	64.54%
Employees	115000
IPO	Mar 01, 1937

P/E	25.83
Forward P/E	15.32
PEG	1.63
P/S	3.58
P/B	3.10
P/C	22.14
P/FCF	21.89
EV/EBITDA	16.89
EV/Sales	4.18
Quick Ratio	1.01
Current Ratio	1.39
Debt/Eq	0.65
LT Debt/Eq	0.57
Option/Short	Yes / Yes

EPS (ttm)	3.59
EPS next Y	6.05
EPS next Q	1.28
EPS this Y	6.29%
EPS next Y	10.55%
EPS next 5Y	9.41%
EPS past 3/5Y	-1.70% 8.23%
Sales past 3/5Y	0.51% 5.08%
EPS Y/Y TTM	-53.44%
Sales Y/Y TTM	6.59%
EPS Q/Q	-17.14%
Sales Q/Q	7.78%
Earnings	Jul 16 BMO
EPS/Sales Surpr.	0.46% 1.49%

Insider Own	0.68%
Insider Trans	0.33%
Inst Own	82.64%
Inst Trans	0.25%
ROA	6.54%
ROE	12.45%
ROIC	7.68%
Gross Margin	52.84%
Oper. Margin	17.77%
Profit Margin	13.91%
SMA20	3.16%
SMA50	4.09%
SMA200	-17.54%
Trades

Shs Outstand	1.74B
Shs Float	1.73B
Short Float	1.27%
Short Ratio	1.68
Short Interest	21.97M
52W High	137.49 -32.57%
52W Low	81.97 13.10%
Volatility	2.95% 2.42%
ATR (14)	2.33
RSI (14)	58.16
Beta	0.58
Rel Volume	0.78
Avg Volume	13.05M
Volume	10,242,575

Perf Week	5.56%
Perf Month	7.43%
Perf Quarter	-10.85%
Perf Half Y	-25.72%
Perf YTD	-26.00%
Perf Year	-31.01%
Perf 3Y	-13.89%
Perf 5Y	-20.90%
Perf 10Y	140.37%
Recom	1.55
Target Price	115.50
Prev Close	94.12
Price	92.71
Change	-1.50%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-22-26	Downgrade	Daiwa Securities	Outperform → Neutral	$92
Oct-10-25	Initiated	The Benchmark Company	Buy	$145
Jul-18-25	Upgrade	Jefferies	Hold → Buy	$145
Jun-16-25	Initiated	Leerink Partners	Market Perform	$143
Oct-08-24	Initiated	Oppenheimer	Outperform	$130
Sep-19-24	Initiated	Piper Sandler	Overweight	$131
Jul-30-24	Downgrade	Edward Jones	Buy → Hold
May-30-24	Initiated	Goldman	Buy	$121
Jul-21-23	Upgrade	Wolfe Research	Underperform → Peer Perform
May-30-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$112
Apr-20-23	Reiterated	Wolfe Research	Underperform	$107 → $103
Apr-20-23	Reiterated	UBS	Buy	$117 → $130
Apr-20-23	Reiterated	Raymond James	Outperform	$116 → $123
Apr-20-23	Reiterated	JP Morgan	Overweight	$118 → $122
Apr-20-23	Reiterated	Bernstein	Outperform	$132 → $133
Apr-20-23	Reiterated	Barclays	Overweight	$125 → $127
Mar-29-23	Initiated	UBS	Buy	$117
Oct-26-22	Initiated	Mizuho	Neutral	$105
Oct-18-22	Initiated	Barclays	Overweight	$118
Oct-12-22	Initiated	Jefferies	Hold	$110

Show Previous Ratings

Today 07:16AM	Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic (MedTech Dive)
Jun-28-26 09:00PM	The Baby Formula Probe Produced a Pile of Evidence. Then the DOJ Dropped the Case. (The Wall Street Journal)
Jun-25-26 09:00AM	Abbott hosts conference call for second-quarter earnings (PR Newswire)
Jun-24-26 08:30AM	ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing (PR Newswire)
06:00AM	MiniMed launches Abbott-made Instinct glucose sensor in Europe (MedTech Dive)
12:00PM	Loading…
Jun-22-26 12:00PM	New Similac survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents (PR Newswire)
Jun-18-26 02:14PM	Living Longer Is Big Business. These Stocks Will Benefit. (Barrons.com)
12:03PM	FiberSense plans CGMs commercial readiness following CE mark (Medical Device Network)
Jun-12-26 02:29PM	Abbott declares 410th consecutive quarterly dividend (PR Newswire)
Jun-11-26 12:01PM	Elfun Trusts Exits Abbott Laboratories, Impacting Portfolio by -1.97% (GuruFocus.com)
Jun-08-26 09:00AM	New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers (PR Newswire)
Jun-06-26 09:00AM	New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis (PR Newswire)
Jun-04-26 03:39PM	A new blood test can help detect colon cancer, but it's not as good as the test you hate to take (MarketWatch)
Jun-03-26 07:53AM	MiniMed expands Abbott partnership to add dual glucose-ketone sensor (MedTech Dive)
May-29-26 08:47AM	Wolfe Research cuts Boston Scientific rating as key growth drivers falter (Investing.com)
07:20AM	Loading…
May-28-26 07:20AM	Abbott obtains CE mark for duo of glucose-ketone monitors (Medical Device Network)
May-27-26 03:02PM	Boston Scientific Is the Worst Performing S&P 500 Stock. Here's Why. (Barrons.com)
09:00AM	Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes (PR Newswire)
07:01AM	ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening (PR Newswire)
May-26-26 09:00AM	Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026 (PR Newswire)
May-22-26 10:04PM	U.S. halts visa issuance for travelers from Ebola-hit African nations - says WSJ (Investing.com)
May-20-26 05:30AM	Biotech Investors Are Tuning Out the MAHA Chaos (The Wall Street Journal)
May-16-26 10:10AM	Trumps More Than 3,700 Trades Astonish Wall Street Insiders (Bloomberg)
May-15-26 04:55AM	10 Quality Stocks That Hit New Lows This Week-and Look Like Bargains (Barrons.com)
01:00AM	Even a High-Priced Market Has Bargains. 10 Undervalued Blue-Chip Stocks. (Barrons.com)
May-13-26 07:08AM	J&J launches improved Shockwave catheter (MedTech Dive)
May-12-26 01:00PM	Abbotts dividend yield near decade peak as investors weigh litigation costs (Investing.com)
May-09-26 07:46AM	Abbott Laboratories: Mispriced Growth Behind Near-Term Noise? (GuruFocus.com)
May-07-26 03:50PM	Glucotrack Submits Blood Glucose Monitoring Technology to FDA (Exec Edge)
May-04-26 05:53PM	Agilent Technologies Names Michael Buckner as CLO (Exec Edge)
06:22PM	Loading…
Apr-29-26 06:22PM	Augment makes first move into $8 trillion distribution sector (FreightWaves)
Apr-27-26 01:14PM	HRS 2026: Medtronic, Boston Scientific and Abbott debut key PFA data (Medical Device Network)
Apr-25-26 12:30PM	Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026 (PR Newswire)
Apr-22-26 11:28AM	How ISRG Just Secured The U.S. Market (Trefis)
Apr-21-26 11:59AM	Study Supports GlucoTracks Blood Glucose Monitoring Implant (Exec Edge)
Apr-20-26 11:18AM	EY on the current state of the medtech industry (Medical Device Network)
Apr-17-26 04:13PM	Why Is Abbott Stock Trending Lower? (Trefis)
03:30PM	New data at AACR 2026 demonstrate advancements in Cancerguard Multi-Cancer Early Detection Test (PR Newswire)
03:02AM	Abbott Laboratories (ABT) Q1 2026 Earnings Call Highlights: Strong Medical Devices Growth Amid ... (GuruFocus.com)
Apr-16-26 03:14PM	Abbott Cuts Profit Forecast After $21 Billion Deal, Shares Fall 4.6% (GuruFocus.com) -6.00%
02:53PM	Abbott Stock Falls After Results Show Pressure in Several Businesses (The Wall Street Journal)
12:46PM	Abbott Laboratories Q1 2026 Earnings Call Summary (Moby)
11:22AM	Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt Sales (The Wall Street Journal)
10:48AM	Abbott Labs shares fall as earnings beat offset by Exact Sciences acquisition drag (Proactive)
09:03AM	Abbott Labs Topples On Post-Exact Sciences Guidance Update (Investor's Business Daily)
08:09AM	Abbott shares dip on soft current-quarter guide; Q1 results in line (Investing.com)
08:05AM	Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Biting. (Barrons.com)
07:56AM	Abbott: Q1 Earnings Snapshot (Associated Press)
07:30AM	Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences (PR Newswire)
05:00AM	Netflix earnings, after the closing bell, follow the stock's sharp rebound (MarketWatch)
Apr-13-26 07:11AM	Abbott Laboratories to contest damages awarded in NEC infant-formula ruling (Just Food)
Apr-10-26 08:00PM	SuperYachts Are Going Through a Growth Phase: More, Bigger, and Pricier. (Barrons.com)
06:58PM	Jury awards total of $70 million in damages in case against Abbott over infant formula (Chicago Tribune)
03:09PM	Cook County jury awards total of $70 million in damages in cases against Abbott over infant formula (Chicago Tribune)
12:12AM	Pulse Biosciences hires Liane Teplitsky as COO (MedTech Dive)
Apr-09-26 09:00AM	New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health (PR Newswire)
Apr-08-26 09:31AM	Tired of AI and Oil? Buy the Robot. (Trefis)
Apr-01-26 06:47AM	Whoop concludes $575m fundraise, adding Abbott as strategic investor (Medical Device Network)
Mar-31-26 04:42PM	Whoop Raises $575 Million at $10.1 Billion Valuation, Reports 103% Growth (GuruFocus.com)
12:58PM	Whoops valuation just tripled to $10 billion (TechCrunch)
12:03PM	Whoop CEO after raising $575 million: Our next step is an IPO (Yahoo Finance)
11:59AM	Whoop valuation tops $10B, setting up highly anticipated IPO (Proactive)
07:32AM	Whoop raises $575M, adds Abbott as strategic investor (MedTech Dive)
06:00AM	Whoop is raising $575 million from investors and star athletes including Cristiano Ronaldo, LeBron James (Yahoo Finance)
06:00AM	Apple watch rival Whoop is raising $575 million from investors including Cristiano Ronaldo, LeBron James (Yahoo Finance)
Mar-30-26 09:00AM	Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR platform (PR Newswire)
Mar-27-26 06:16AM	Philips wins FDA clearance for imaging device developed with Edwards (MedTech Dive)
Mar-26-26 06:55PM	Better Together: Why Abbott Kept an In-Person Workforce During Pandemic (WSJ)
06:06PM	Building a Workforce for Breakthrough Innovation (WSJ)
03:00PM	How Goode Foods went from family biz to viral brand (Yahoo Finance Video)
09:00AM	Abbott hosts conference call for first-quarter earnings (PR Newswire)
Mar-24-26 08:00AM	John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard tests, encouraging colon cancer screening (PR Newswire)
06:05AM	Abbott closes $23 billion deal to buy Madison-based Exact Sciences (Milwaukee Journal Sentinel)
Mar-23-26 09:37AM	Synlait outlines recovery roadmap after H1 loss (Just Food)
08:50AM	Abbott completes acquisition of Exact Sciences (PR Newswire)
Mar-20-26 09:00AM	Abbott acquisition of Exact Sciences set to close on March 23, 2026 (PR Newswire)
06:57AM	Abbott to close $21B Exact Sciences acquisition Monday (MedTech Dive)
Mar-16-26 07:30PM	This Dividend King With a 54-Year Dividend Streak Is Down 13% YTD. Time to Buy the Dip? (Barchart)
Mar-12-26 03:00AM	Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management (PR Newswire)
Mar-11-26 03:26PM	3 Analyst-Approved Stocks With Fat Yields That Could Rally 27% or More (Barchart)
11:00AM	Abbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team' (PR Newswire)
06:00AM	More workers are taking a phased approach to retirement and employers are starting to help (Yahoo Finance)
05:27AM	Abbott price target lowered to $136 from $140 at Citi (TipRanks)
Mar-10-26 10:58AM	Arrow Exploration CEO on Colombia drilling success - One2One Investor Forum (Proactive)
09:45AM	Abbott (ABT) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
Mar-09-26 05:50PM	Abbott (ABT) Rises Higher Than Market: Key Facts (Zacks)
Mar-06-26 11:30AM	Why Is Boston Scientific (BSX) Down 6% Since Last Earnings Report? (Zacks)
09:52AM	Hologic's Diagnostics Strength in Focus: Is More Upside Ahead? (Zacks)
Mar-05-26 03:00AM	Cancer tests are becoming more precise and guiding pharma R&D (Pharma Voice)
Mar-04-26 09:00AM	Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Mar-03-26 09:10AM	Medtronic Debuts MiniMed Go Smart MDI With Simplera Sensor in Europe (Zacks)
Mar-02-26 05:50PM	Abbott (ABT) Stock Sinks As Market Gains: Here's Why (Zacks)
01:32AM	Abbott wins FDA approval for updated heart failure monitoring device (MedTech Dive)
Mar-01-26 11:05PM	2 Reasons to Like ABT and 1 to Stay Skeptical (StockStory)
Feb-26-26 05:00PM	Grail's Stock Dropped 50% on Friday. Investors Still Have High Hopes for the Biotech. (Barrons.com)
11:21AM	Intuitive Surgical or Abbott: Which MedTech Stock Is a Better Bet Now? (Zacks)
08:14AM	Is Medtronic Stock Underperforming the S&P 500? (Barchart)
03:36AM	Is Boston Scientific Stock Underperforming the Dow? (Barchart)
Feb-25-26 09:11AM	Is Abbott Laboratories Stock Underperforming the Nasdaq? (Barchart)
Feb-24-26 11:33AM	AdvaMed names Jake Leach as chair of diabetes sector (MedTech Dive)

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment focuses on branded generic pharmaceuticals that are manufactured worldwide and marketed and sold outside the United States, primarily in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternative care testing sites. The Nutritional Products segment oversees the worldwide sale of pediatric and adult nutritional products. The Medical Devices segment offers a broad range of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, as well as diabetes care and continuous glucose monitoring products. It also provides neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

CFO & Executive VP of FinanceMr. Philip P. Boudreau

Executive VP and Group President of Established Pharmaceuticals & Nutritional ProductsMr. Daniel Gesua Sive Salvadori

Executive Vice President of Diabetes CareMr. Christopher J. Scoggins

Executive VP & Group President of Medical DevicesMs. Lisa D. Earnhardt

Senior VP of Business & Technology Services and Chief Information OfficerMs. Sabina Ewing

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stratton John G	Director	May 07 '26	Buy	86.82	2,000	173,640	23,319	Jun 18 05:08 PM
Robert J. Alpern	Retired Director	May 15 '26	Proposed Sale	85.25	7,587	646,791		May 15 04:15 PM
STARKS DANIEL J	Director	Apr 27 '26	Buy	92.65	10,000	926,537	6,751,103	Apr 28 07:37 PM
Robert J. Alpern	Retired Director	Apr 27 '26	Proposed Sale	92.55	29,211	2,703,457		Apr 27 06:34 PM
Boudreau Philip P	EVP AND CFO	Apr 23 '26	Buy	91.50	2,200	201,300	2,200	Apr 27 05:34 PM
Shroff Eric	Senior Vice President	Mar 02 '26	Sale	115.58	709	81,946	39,164	Mar 03 08:20 PM
Salvadori Daniel Gesua Sive	EVP AND GROUP PRESIDENT	Mar 02 '26	Sale	115.58	885	102,288	146,377	Mar 03 08:10 PM
Morrone Louis H.	EXECUTIVE VICE PRESIDENT	Mar 02 '26	Sale	115.58	1,144	132,224	76,843	Mar 03 08:06 PM
Moreland Mary K	EXECUTIVE VICE PRESIDENT	Mar 02 '26	Sale	115.58	613	70,851	104,291	Mar 03 08:00 PM
MCCOY JOHN A. JR.	VICE PRESIDENT AND CONTROLLER	Mar 02 '26	Sale	115.58	585	67,614	24,628	Mar 03 07:55 PM
Cushman Elizabeth C.	EVP, GC AND SECRETARY	Mar 02 '26	Sale	115.58	263	30,398	38,573	Mar 03 07:39 PM
Eric Shroff	Officer	Mar 02 '26	Proposed Sale	115.58	709	81,946		Mar 02 08:36 PM
Daniel Gesua Sive Salvadori	Officer	Mar 02 '26	Proposed Sale	115.58	885	102,288		Mar 02 08:23 PM
Louis H. Morrone	Officer	Mar 02 '26	Proposed Sale	115.58	1,144	132,223		Mar 02 08:16 PM
Mary K. Moreland	Officer	Mar 02 '26	Proposed Sale	115.58	613	70,850		Mar 02 08:05 PM
John A. McCoy, Jr.	Officer	Mar 02 '26	Proposed Sale	115.58	585	67,614		Mar 02 07:59 PM
Elizabeth C. Cushman	Officer	Mar 02 '26	Proposed Sale	115.58	263	30,397		Mar 02 07:53 PM
STARKS DANIEL J	Director	Feb 04 '26	Buy	108.73	10,000	1,087,331	6,738,817	Feb 06 08:04 AM
Ford Robert B	CHAIRMAN AND CEO	Jan 23 '26	Buy	107.13	18,800	2,013,967	216,203	Jan 26 08:02 AM
Shroff Eric	Senior Vice President	Nov 25 '25	Sale	128.02	1,586	203,043	30,384	Nov 25 04:17 PM
Eric Shroff	Officer	Nov 25 '25	Proposed Sale	128.02	1,586	203,042		Nov 25 04:08 PM
Boudreau Philip P	EVP AND CFO	Aug 08 '25	Sale	134.55	5,550	746,758	51,003	Aug 11 05:53 PM
Boudreau Philip P	Officer	Aug 08 '25	Proposed Sale	134.55	5,550	746,758		Aug 08 06:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

$100 Off Your First Year Get Elite For Just $199.50

ABT

Abbott Laboratories

Upgrade your Finviz experience